Endometrial Cancer Vincerx Pharma Provides Key Strategic UpdateBy adminJune 6, 20220 Prioritizing Phase 1b VIP152 studies to focus on double-hit DLBCL and CLL Continuing to advance next-generation modular bioconjugation platform; IND…
